Hospital Universitario de Valladolid -ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2023

  1. Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

    Cancers, Vol. 15, Núm. 11

2020

  1. Risk factors and outcome of COVID-19 in patients with hematological malignancies

    Experimental Hematology and Oncology, Vol. 9, Núm. 1